Evidence map›Paper›PMID 36554020›Full record

ArticleHealthcare (Basel, Switzerland)2022

A Hybrid Risk Factor Evaluation Scheme for Metabolic Syndrome and Stage 3 Chronic Kidney Disease Based on Multiple Machine Learning Techniques.

Mao-Jhen Jhou, Ming-Shu Chen, Tian-Shyug Lee, Chih-Te Yang, Yen-Ling Chiu, Chi-Jie Lu

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Health Informatics: The Foundations of Public Health.Healthcare (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Mao-Jhen JhouGraduate Institute of Business Administration, Fu Jen Catholic University, New Taipei City 242062, Taiwan.ORCID 0000-0003-1250-7434
Ming-Shu ChenDepartment of Healthcare Administration, College of Healthcare & Management, Asia Eastern University of Science and Technology, New Taipei City 220303, Taiwan.ORCID 0000-0002-2713-3546
Tian-Shyug LeeGraduate Institute of Business Administration, Fu Jen Catholic University, New Taipei City 242062, Taiwan.ORCID 0000-0001-9280-0643
Chih-Te YangDepartment of Business Administration, Tamkang University, New Taipei City 251301, Taiwan.ORCID 0000-0001-7234-3107
Yen-Ling ChiuDepartment of Medical Research, Department of Medicine, Far Eastern Memorial Hospital, New Taipei City 22056, Taiwan.ORCID 0000-0003-4504-5571
Chi-Jie LuGraduate Institute of Business Administration, Fu Jen Catholic University, New Taipei City 242062, Taiwan.ORCID 0000-0002-7911-2253
Fu Jen Catholic University · TWAsia University · TWNational Taiwan University · TWTamkang University · TW

Funding

Fu Jen catholic University A011181National Science and Technology Council NSTC 110-2221-E-030- 010National Science and Technology Council NSTC-110-2221-E-161- 003
6 · The paper itself

Abstract

With the rapid development of medicine and technology, machine learning (ML) techniques are extensively applied to medical informatics and the suboptimal health field to identify critical predictor variables and risk factors. Metabolic syndrome (MetS) and chronic kidney disease (CKD) are important risk factors for many comorbidities and complications. Existing studies that utilize different statistical or ML algorithms to perform CKD data analysis mostly analyze the early-stage subjects directly, but few studies have discussed the predictive models and important risk factors for the stage-III CKD high-risk health screening population. The middle stages 3a and 3b of CKD indicate moderate renal failure. This study aims to construct an effective hybrid important risk factor evaluation scheme for subjects with MetS and CKD stages III based on ML predictive models. The six well-known ML techniques, namely random forest (RF), logistic regression (LGR), multivariate adaptive regression splines (MARS), extreme gradient boosting (XGBoost), gradient boosting with categorical features support (CatBoost), and a light gradient boosting machine (LightGBM), were used in the proposed scheme. The data were sourced from the Taiwan health examination indicators and the questionnaire responses of 71,108 members between 2005 and 2017. In total, 375 stage 3a CKD and 50 CKD stage 3b CKD patients were enrolled, and 33 different variables were used to evaluate potential risk factors. Based on the results, the top five important variables, namely BUN, SBP, Right Intraocular Pressure (R-IOP), RBCs, and T-Cho/HDL-C (C/H), were identified as significant variables for evaluating the subjects with MetS and CKD stage 3a or 3b.

Indexed as

chronic kidney disease (CKD)end-stage kidney disease (ESKD)hybrid risk factormachine learning (ML)Metabolic syndrome (MetS)

Identifiers

PMID36554020
PMCPMC9778302
OpenAlexW4312126397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.